ASSOCIATED PRESS / AUGUST. 12
German Health Minister Karl Lauterbach arrives at a press conference in Berlin, Germany, on Friday about Germany’s existing Corona.
BERLIN >> Germany’s fitness minister said Friday that European Union drug regulators may allow the use of vaccines that are effective against two variants of the coronavirus.
German Health Minister Karl Lauterbach said he expected the European Medicines Agency to meet on Sept. 1 for a vaccine that would provide coverage against the original virus and the omicron variant, also known as BA. 1.
The EU company is likely to meet on Sept. 27 for a combined vaccine supporting the original virus and the BA. 5 variant that is responsible for the latest global outbreak of COVID-19 cases, Lauterbach said.
Germany has purchased sufficient quantities of any of the vaccines and will begin rolling them out a day after receiving the authorization, he said.
The U. S. Food and Drug Administration (FDA)The U. S. Food and Drug Administration said the combination vaccines, known as “bivalent” or “multivalent” vaccines, will allow boosters to maintain the appearance of the original coronavirus vaccines while offering greater coverage against the new variants.
This technique is used with influenza vaccines, which are adjusted according to circulating variants and can protect against four strains of influenza.
Lauterbach, a qualified epidemiologist, said the coronavirus’ continued mutation remains high.
“There are still many variants that can develop,” he said, noting the sheer number of infections around the world, adding other people with weakened immune systems, allowing the virus to persist for months.
Problems with comments? Learn here.
Click here to see our full information on the coronavirus outbreak. Submit your coronavirus news suggestion.
top_noticias_última hour
top_noticias_última hour
Back to top